Table 4 Adverse events during the study period.
Adverse event | Total number n (%) | CTCAE Grade 1 n (%) | CTCAE Grade 2 n (%) | CTCAE Grade 3 n (%) |
|---|---|---|---|---|
Citrate reaction | 23 (62) | 18 (49) | 5 (14) | |
Diarrhea | 15 (41) | 10 (27) | 5 (14) | |
Pain | 14 (38) | 9 (24) | 5 (14) | |
Nausea | 12 (32) | 8 (22) | 4 (11) | |
Intestinal bloating | 9 (24) | 6 (16) | 3 (8) | |
Dizziness | 7 (19) | 2 (5) | 5 (14) | |
Flu-like symptoms | 5 (14) | 2 (5) | 3 (8) | |
Thrombocytopenia | 4 (11) | 2 (5) | 2 (5) | |
Vomiting | 4 (11) | 4 (11) | ||
Itching at injection site | 2 (5) | 2 (5) | ||
Heat sensation | 1 (3) | 1 (3) | ||
Erythrocyturiaa | 1 (3) | 1 (3) | ||
Pneumonia | 1 (3) | 1 (3) | ||
Elevated PTT | 1 (3) | 1 (3) | ||
Insomnia | 1 (3) | 1 (3) | ||
Swelling at injection site | 1 (3) | 1 (3) | ||
Tachycardia | 1 (3) | 1 (3) |
